As President of Narrativa, one of the fastest growing AI companies in the world, Jennifer helps to bring automated content and reporting to multiple industries.
Narrativa launches TivaSync, a new AI Agentic Growth Company for regulated industries, in partnership with Convertr https://t.co/0dIGv0upq4 via @ein_news
The Leukemia & Lymphoma Society BAML and Narrativa grow partnership to accelerate AI-automated regulatory documentation @LLSusa@NarrativaAI https://t.co/6T11OfCfKl via @ein_news
📸 That's a wrap for SCOPE 2025! 📸
👩🔬 From exciting conversations about the future of #ClinicalTrials to catching up with industry leaders, it was an event to remember.
🤳 Here are some snapshots from the experience!
#SCOPE2025#LifeSciences#SCOPESummit
🚀 Get ready to revolutionize your approach to clinical documentation and supercharge your pipeline growth with the power of AI!
📅 Date: Wednesday, March 20, 2024
🕒 Time: 12:00 pm - 12:45 pm EST
🔗 Reserve your seat now: https://t.co/bJAkuZIRSb
💻 #ChatGPT isn't built for business. Discover why organizations like yours are choosing Narrativa's #GenerativeAI platform to accelerate their potential.
⬇️⬇️⬇️
https://t.co/iEhw4uuP7M
🚀 Our president @JenniferBitti17 had an amazing time in #NewYorkCity connecting with mentors, VCs, and fellow startups at @NYUStern. We're thrilled about the growth opportunities that lie ahead for us!
💊 Did you know? The cost of successful #ClinicalTrials can soar up to a whopping $2.6 billion and takes a staggering 10-15 years!
💡 Automating the documentation process with #GenerativeAI saves hundreds of hours and money.⬇️⬇️
https://t.co/ixbZuWqaEA